Eupraxia Pharmaceuticals, Inc.

Eupraxia Pharmaceuticals is a clinical-stage biotechnology company focused on developing locally delivered, extended-release alternatives to existing drugs. Their primary goal is to provide patients with better treatment options by delivering the right dose of medication, to the right place, for the right amount of time, in indications with a high unmet medical need. Eupraxia's proprietary Diffusphere™ technology platform allows for the controlled release of drugs, potentially leading to longer-lasting therapy and fewer side effects compared to traditional approaches.

The company's lead product candidate, EP-104, is being developed to address significant unmet medical needs in knee osteoarthritis and eosinophilic esophagitis. EP-104IAR, the formulation for osteoarthritis, is a long-acting intra-articular injection of fluticasone propionate, while EP-104GI is being developed for the treatment of eosinophilic esophagitis. Eupraxia's pipeline also includes non-clinical candidates in areas such as post-surgical pain, anti-infective treatments, veterinary medicine, and potentially oncology. The company has experienced management and board members with extensive experience in medical, life sciences, and public companies.

Eupraxia Pharmaceuticals is a clinical-stage biotechnology company focused on developing locally delivered, extended-release alternatives to existing drugs. They leverage their proprietary Diffusphere™ technology to deliver the right dose of the right drug to the right place for the right amount of time, addressing therapeutic areas with high unmet medical needs and striving to improve patient benefit by delivering targeted, long-lasting activity with fewer side effects.

Eupraxia Pharmaceuticals promotes a culture that values patient-centricity, ethical and social responsibility, creativity, and excellence. They prioritize a workplace that inspires innovation and fosters work/life balance, encouraging employees to bring fresh ideas to the table and work together to solve complex problems. Their leadership team emphasizes doing the right thing, inspiring a culture of excellence at all levels.

Eupraxia Pharmaceuticals is committed to fostering a diverse and inclusive workplace that values ethical and socially responsible business practices. They believe that creativity thrives in an environment that embraces ingenuity, passion, and freedom of exploration, and actively cultivate diversity, inclusion, equity, and sustainable practices within their company.